title: Continue with long term sulfonylureas in patients with mutations in the KCNJ11 gene when there is evidence of response even if insulin treatment is still required.
authors.forename: T
authors.initials: T
authors.lastname: Babiker
authors.forename: M H
authors.initials: MH
authors.lastname: Shepherd
authors.forename: A T
authors.initials: AT
authors.lastname: Hattersley
mesh_terms: D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D005905:Glyburide / Q000627:therapeutic use*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use*; D008297:Male; D020125:Mutation, Missense / Q000235:genetics*; D024661:Potassium Channels, Inwardly Rectifying / Q000235:genetics*; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin; D024661:Potassium Channels, Inwardly Rectifying; D013453:Sulfonylurea Compounds; D005905:Glyburide